https://doi.org/10.1136/gutjnl-2022-327909
D
Dominic Denk
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
15
Papers
646
Citations
6
h-index
5
i10-index
Dominic Denk is an academic researcher from Goethe University Frankfurt. The author has contributed to research in topics: Hepatocellular Carcinoma Treatment and Prognosis & Cancer Immunotherapy and Biomarkers & Pomegranate: compositions and health benefits. The author has an h-index of 6, co-authored 13 publications.
ORCID: 0000-0002-4887-1492Papers by this author
worksCombining ferroptosis induction with MDSC blockade renders primary tumours and metastases in liver sensitive to immune checkpoint blockade
2023 · Gut · 216 citations
IL-17RA signaling provides dual tumor-suppressor function during late-stage colorectal carcinogenesis
2025 · Immunity · 10 citations
https://doi.org/10.1016/j.immuni.2025.02.005
Effect of the mitophagy inducer urolithin A on age-related immune decline: a randomized, placebo-controlled trial
2025 · Nature Aging · 3 citations
https://doi.org/10.1038/s43587-025-00996-x
Author Correction: Effect of the mitophagy inducer urolithin A on age-related immune decline: a randomized, placebo-controlled trial
2026 · Nature Aging · 0 citations
https://doi.org/10.1038/s43587-025-01060-4
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat